Direct-to-Consumer Advertising of Prescription Drugs: A Strategic Analysis

Published Online:https://doi.org/10.1287/mksc.1080.0411

References

  • Aikin K. FDA's physician survey on DTC Rx drug ads shows health benefits. CDER News Along the Pike (2003) 9(1, February 21Google Scholar
  • Aikin K., Swasy J. L., Braman A. C. Patient and physician attitudes and behaviors associated with direct-to-consumer promotion of prescription drugs—Summary of FDA survey research results. (2004) . Food and Drug Administration, Center for Drug Evaluation and Research, Division of Drug Marketing, Advertising, and Communications, Washington, DCGoogle Scholar
  • Amaldoss W., Rapoport A. Collaborative product and market development: Theoretical implications and experimental evidence. Marketing Sci. (2005) 24(3):396–414LinkGoogle Scholar
  • Amir R. Modeling imperfectly appropriable R&D via spillovers. Internat. J. Indust. Organ. (2000) 18(7):1013–1032CrossrefGoogle Scholar
  • Ananatharaman R., Parthan A., Shepherd M. Examination of the relationship between direct-to-consumer advertising expenditure and price. Drug Inform. J. (2005) 39(1):13–24CrossrefGoogle Scholar
  • Bass F., Krishnamoorthy A., Prasad A., Sethi S. Generic and brand advertising strategies in a dynamic duopoly. Marketing Sci. (2005) 24(4):556–571LinkGoogle Scholar
  • Becker G. S., Murphy K. M. A simple theory of advertising as good or bad. Quart. J. Econom. (1993) 108(4):941–964CrossrefGoogle Scholar
  • Cacioppo J. T., Petty R. E., Kao C., Rodriguez R. Central and peripheral routes to persuasion: An individual difference perspective. J. Personality Soc. Psych. (1986) 51(5):1032–1043CrossrefGoogle Scholar
  • Caves R., Whinston M., Hurwitz M., Pakes A., Temin P. Patent expiration, entry, and competition in the U.S. pharmaceutical industry: Comments and discussion. Brookings Papers Econom. Activity (1991) 12(1):1–66CrossrefGoogle Scholar
  • Ching A., Ishihara M. The effects of detailing on prescribing decisions under two-sided learning. (2008) . Mimeo, University of Toronto, TorontoGoogle Scholar
  • Chintagunta P. K., Desiraju R. Strategic pricing and detailing behavior in international markets. Marketing Sci. (2005) 24(1):67–80LinkGoogle Scholar
  • Desiraju R., Nair H., Chintagunta P. K. Diffusion of new pharmaceutical drugs in developing and developed nations. Internat. J. Res. Marketing (2004) 21(4):341–357CrossrefGoogle Scholar
  • Duhamel L., Dievler A., Price R. Prescription drugs: FDA oversight of direct-to-consumer advertising has limitations. (2002) . Report to Congressional Requesters, United States General Accounting Office, Washington, DCGoogle Scholar
  • Gerstner E., Hess J. Pull promotions and channel coordination. Marketing Sci. (1995) 14(1):43–60LinkGoogle Scholar
  • Grossman G. M., Shapiro C. Informative advertising with differentiated products. Rev. Econom. Stud. (1984) 51(1):63–81CrossrefGoogle Scholar
  • Grünfeld L. A. Meet me halfway but don't rush: Absorptive capacity and strategic R&D investment revisited. Internat. J. Indust. Organ. (2003) 21(8):1091–1109CrossrefGoogle Scholar
  • Harkins S. G., Petty R. E. Effects of source magnification of cognitive effort on attitudes: An information-processing view. J. Personality Soc. Psych. (1981) 40(3):401–413CrossrefGoogle Scholar
  • Ho T. H., Lim N., Camerer C. Modeling the psychology of consumer and firm behavior with behavioral economics. J. Marketing Res. (2006) 43(3):307–331CrossrefGoogle Scholar
  • Hurwitz M. A., Caves R. E. Persuasion or information? Promotion and the shares of brand name and generic pharmaceuticals. J. Law Econom. (1988) 31(2):299–320CrossrefGoogle Scholar
  • Iizuka T., Jin G. The effect of prescription drug advertising on doctor visits. J. Econom. Management Strategy (2005) 14(3):701–727CrossrefGoogle Scholar
  • Iizuka T., Jin G. Direct to consumer advertising and prescription choice. (2006) . Working paper, Department of Economics, University of Maryland, College ParkGoogle Scholar
  • Jong G. W., Stricker B., Sturkenboom M. Marketing in the lay media and prescriptions of terbinafine in primary care: Dutch cohort study. British Medical J. (2004) 328:931CrossrefGoogle Scholar
  • Kamien M., Zang I. Meet me halfway: Research joint ventures and absorptive capacity. Internat. J. Indust. Organ. (2000) 18(7):995–1012CrossrefGoogle Scholar
  • Krishnamurthy S. Enlarging the pie vs. increasing one's slice: An analysis of the relationship between generic and brand advertising. Marketing Lett. (2000) 11(1):37–48CrossrefGoogle Scholar
  • Manchanda P., Xie Y., Youn N. The role of targeted communication and contagion in product adoption. Marketing Sci. (2008) 27(6):961–976LinkGoogle Scholar
  • Meurer M., Stahl D. O. Informative advertising and product match. Internat. J. Indust. Organ. (1994) 12(1):1–19CrossrefGoogle Scholar
  • Mintzes B. What are the public health implications? Direct-to-consumer advertising of prescription drugs in Canada. (2006) . Report, Health Council of Canada, TorontoGoogle Scholar
  • Narayanan S., Desiraju R., Chintagunta P. K. Return on investment implications for pharmaceutical promotional expenditures: The role of marketing-mix interactions. J. Marketing (2004) 68(4):90–105CrossrefGoogle Scholar
  • Nelson P. Advertising as information. J. Political Econom. (1974) 82(4):729–754CrossrefGoogle Scholar
  • Neslin S. ROI Analysis of Pharmaceutical Promotion (RAPP): An independent study. (2001) . http://www.rxpromoroi.org/rapp/Google Scholar
  • Petty R. E., Cacioppo J. T., Goldman R. Personal involvement as a determinant of argument-based persuasion. J. Personality Soc. Psych. (1981) 41(5):847–855CrossrefGoogle Scholar
  • Raju J., Sethuraman R., Dhar S. K. The introduction and performance of store brands. Management Sci. (1995) 41(6):957–978LinkGoogle Scholar
  • Rapoport A., Amaldoss W. Mixed strategies and iterative elimination of strongly dominated strategies: An experimental investigation of states of knowledge. J. Econom. Behav. Organ. (2000) 4:483–521CrossrefGoogle Scholar
  • Rapoport A., Amaldoss W. Mixed strategy play in single-stage all-pay auctions with symmetric players. J. Econom. Behav. Organ. (2004) 4:585–607CrossrefGoogle Scholar
  • Rapoport A., Boebel R. B. Mixed strategies in strictly competitive games: A further test of the minimax hypothesis. Games Econom. Behav. (1992) 4:261–283CrossrefGoogle Scholar
  • Rizzo J. A. Advertising and competition in the ethical pharmaceutical industry: The case of antihypertensive drugs. J. Law Econom. (1999) 42(1):89–116CrossrefGoogle Scholar
  • Rosenthal M., Berndt E., Donohue J., Epstein A., Frank R., Cutler D. M., Garber A. M. Demand effects of recent changes in prescription drug promotion. Frontiers in Health Policy Research (2003) 6(MIT Press, Cambridge, MA) 1–26CrossrefGoogle Scholar
  • Shubik M., Levitan R.Market Structure and Behavior (1980) (Harvard University Press, Cambridge, MA) CrossrefGoogle Scholar
  • Shugan S. Endogeneity in marketing decision models. Marketing Sci. (2004) 23(1):1–3LinkGoogle Scholar
  • Soberman D. Research note: Additional learning and implications on the role of informative advertising. Management Sci. (2004) 50(12):1744–1750LinkGoogle Scholar
  • Wang Y., Krishna A. Time share allocations: Theory and experiment. Management Sci. () 12(8):1223–1237LinkGoogle Scholar
  • Weissman J. S., Blumenthal D., Silk A. J., Newman M., Zapert K., Leitman R., Feibelmann S. Physicians report on patient encounters involving direct-to-consumer advertising. Health Affairs (2004) W4(April 28):219–233Google Scholar
  • Wittink D. R. Analysis of ROI for pharmaceutical promotions. (2002) . Unpublished study, Association of Medical Publications, http://rxpromoroi.org/arpp/index.htmlGoogle Scholar
  • Wittner P. Generics defense strategies: Effective brand protection through patent, formulation, OTC and DTC strategies. (2004) . Management report, Business Insights Ltd., LondonGoogle Scholar
  • Wosinska M. Just what the patient ordered? Direct-to-consumer advertising and the demand for pharmaceutical products. (2002) . HBS Marketing Research Paper 02–04, Harvard Business School, Cambridge, MAGoogle Scholar
  • Wosinska M. Direct-to-consumer advertising and drug therapy compliance. J. Marketing Res. (2005) 42(3):323–332CrossrefGoogle Scholar
  • Zachry W. M., Shepherd M. D., Hinich M. J., Wilson J. P., Brown C. M., Lawson K. A. Relationship between direct-to-consumer advertising and physician diagnosing and prescribing. Amer. J. Health System Pharmacy (2002) 59:42–49CrossrefGoogle Scholar
INFORMS site uses cookies to store information on your computer. Some are essential to make our site work; Others help us improve the user experience. By using this site, you consent to the placement of these cookies. Please read our Privacy Statement to learn more.